cytarabine has been researched along with Erythema Nodosum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, M; Liang, G; Xu, X; Zhang, L | 1 |
| Aydinok, Y; Cetingül, N; Kantar, M; Kavakli, K; Oniz, H | 1 |
2 other study(ies) available for cytarabine and Erythema Nodosum
| Article | Year |
|---|---|
Acute myeloid leukemia presenting as erythema nodosum: A case report.
Topics: Antineoplastic Agents; Bone Marrow Examination; Cytarabine; Daunorubicin; Erythema Nodosum; Fatal Outcome; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Middle Aged; Recurrence; Remission Induction | 2017 |
Skin toxicity after administration of low-dose cytarabine.
Topics: Antimetabolites, Antineoplastic; Child; Cytarabine; Erythema Nodosum; Exanthema; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Skin Diseases; Urticaria | 1999 |